Nestin Expression and the Survival of Patients With Digestive Tract Cancers: A Systematic Review and Meta-Analysis
Turkish Journal of Gastroenterology · 15.09.2023 · 34 (9) · 902-910
DOI: 10.5152/tjg.2023.22485 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Turkish Journal of Gastroenterology, online erschienen am 15.09.2023. Verfasst von Lumi Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Chongqing University Cancer Hospital, Chongqing, China. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Stomach Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aims: Several cancers have been associated with poor prognoses based on nestin, a confirmed marker of cancer stem cells. However, there is conflicting evidence regarding the prognostic value of tumor nestin expression in patients with digestive tract cancers. An investigation of the association between nestin and survival in patients with digestive tract cancers was performed in this meta-analysis. Materials and Methods: Meta-analyses were conducted using PubMed, Embase, and Web of Science databases to search for cohort studies. We analyzed the data using a random-effects model that incorporates differences between studies.
Results
The pooled analysis showed a negative association between nestin expression and overall survival (hazard ratio: 1.38, 95% CI: 1.11 to 1.72, P = .004, I2 = 68%) and disease-free survival (hazard ratio: 1.48, 95% CI: 1.12 to 1.96, P = .005, I2 = 56%). Subgroup analysis showed that nestin expression was associated with poorer overall survival in gastric cancer (hazard ratio: 1.46, P < .001) and liver cancer (hazard ratio: 2.05, P < .001) patients, but not in colorectal cancer (hazard ratio: 1.03, P = .89) or pancreatic cancer (hazard ratio: 0.96, P = .80) patients. Further subgroup analysis showed a consistent association between nestin expression and poor overall survival in Asian and non-Asian studies, and in studies with univariate and multivariate regression models.
Conclusion
To sum up, the presence of high nestin expression in digestive tract cancer patients is associated with poorer survival, particularly in patients with gastric and liver cancers Cite this article as: Huang L, Chen L, Wang Y, et al. Nestin expression and the survival of patients with digestive tract cancers: A systematic review and meta-analysis. Turk J Gastroenterol. 2023;34(9):902-910.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Chongqing University Cancer Hospital, Chongqing, China.
- Huaiyin District Jinan Shandong Province, China.
Zitieren
APA
Huang, L., Chen, L., Wang, Y., Zhang, F., Wang, T., Li, D., Wang, C., & Ma, H. (2023). Nestin Expression and the Survival of Patients With Digestive Tract Cancers: A Systematic Review and Meta-Analysis. Turkish Journal of Gastroenterology, 34(9), 902-910. https://doi.org/10.5152/tjg.2023.22485
Vancouver
Huang L, Chen L, Wang Y, Zhang F, Wang T, Li D, et al. Nestin Expression and the Survival of Patients With Digestive Tract Cancers: A Systematic Review and Meta-Analysis. Turkish Journal of Gastroenterology. 2023;34(9):902-910. doi:10.5152/tjg.2023.22485
BibTeX
@article{Huang2023,
author = {Huang, Lumi and Chen, Lihui and Wang, Yiming and Zhang, Fucheng and Wang, Ting and Li, Dairong and Wang, Chunmei and Ma, Huiwen},
title = {Nestin Expression and the Survival of Patients With Digestive Tract Cancers: A Systematic Review and Meta-Analysis},
journal = {Turkish Journal of Gastroenterology},
year = {2023},
volume = {34},
number = {9},
pages = {902--910},
doi = {10.5152/tjg.2023.22485}
}
EUVIMED